Press Releases Herantis Pharma Oyj

Equities

HRTIS

FI4000087861

Delayed Nasdaq Helsinki Other stock markets 09:37:50 28/06/2024 BST			5-day change	1st Jan Change
1.635 ^EUR	+0.31%		-2.68%	+3.81%

05-20	Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096	CI
03-06	Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle	01-26	AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s extraordinary general meeting of shareholders November 17, 2023	11-16	PU
Herantis Pharma Oyj : Notice to Convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders November 17, 2023	11-16	PU
Herantis Pharma Plc's shares subscribed with option rights	19/07/23	AQ
Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096	04/07/23	AQ
Herantis Pharma Oyj: Managers' Transactions - Aki Prihti	20/06/23	AQ
Herantis Pharma Oyj: Managers' Transactions - Timo Veromaa	20/06/23	AQ
Herantis Pharma Oyj: Managers' Transactions - Frans Wuite	20/06/23	AQ
Herantis Pharma Oyj: Managers' Transactions - Tone Kvåle	09/06/23	AQ
Herantis Pharma Oyj: Managers' Transactions - Antti Vuolanto	09/06/23	AQ
Herantis Pharma Oyj: Managers' Transactions - Henri Huttunen	09/06/23	AQ
Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel	02/06/23	AQ
Herantis Pharma to participate in Redeye Hosted Events: Investor Lunch and Redeye Growth Day	22/05/23	PU
Herantis Pharma to participate in Bio€quity Europe 2023 in Dublin May 2023	02/05/23	AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s Annual General Meeting of shareholders 2023	26/04/23	PU
Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders	20/04/23	AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s Annual General Meeting of shareholders 2023	19/04/23	PU
Herantis Pharma announces first healthy volunteer dosed in the Phase 1a clinical study for the Parkinson's disease drug candidate, HER-096	19/04/23	AQ
Herantis Pharma Oyj : has signed European Innovation Council (EIC) Accelerator grant agreement	12/04/23	PU
Herantis Pharma to participate in Nordic Health Summit Japan 2023	06/04/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Herantis Pharma Oyj

Equities

HRTIS

FI4000087861

Press Releases

Filters